Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TETRAHYDROZOLINE vs TEZEPELUMAB-EKKO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TETRAHYDROZOLINE vs TEZEPELUMAB-EKKO: Safety Overview

Metric TETRAHYDROZOLINE TEZEPELUMAB-EKKO
Total FAERS Reports 722 4,398
Deaths Reported 20 190
Death Rate 2.8% 4.3%
Hospitalizations 31 798
Average Patient Age 52.4 yrs 56.9 yrs
% Female Patients 47.5% 74.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Strategic Sourcing Services LLC N/A
Route OPHTHALMIC N/A
Marketing Status Prescription Prescription